Epigene Channel LLC

Healthy Living

Vanadium complex have virucidal activity against HIV, RNA virus, Glyburide can inhibits pyroptosis( self destruction ) of HIV infected CD4+ cells. Combination of these drug can potentiate HAART drugs.

Shareable draft

Check out Epigene Channel LLC on @MedStartr Today Vanadium complex have virucidal activity against HIV, RNA virus, Glyburide can inhibits pyroptosis( self destruction ) of HIV infected CD4+ cells. Combination of these drug can potentiate HAART drugs. #HealthyLiving #MedMo #MedStartrVentures

https://www.medstartr.ai/s/ihguKwLMXkw

Get Involved in Epigene Channel LLC

How We Help

Company Info

Clinical & IP

🔬

Clinical Validation

<p>Patient observation over a period of 5 years was noted and documented. Lab improvement in CD4 T cell count, CD8 T cell count and CD4/CD8 cell  ratio is consistent, varifiable and objective measurement. HIV RNA titer is not only reduces to undetectable levels but also remains undetectable for a long period even after discontinuing antiviral therapy. Delayed viral rebound has been documented for 4 months after discontinuing all treatment without detectable virus. Most of  these patients are already on HAARTherapy with suppressed viral titer except in non compliant patient and in patients who develop adverse effects and become non compliant. Some of the patients were not using HAART or any antivirals however benefited through their own immune response which resulted is dissapearance od detectabl virus for the first time for that patient...</p>

🛡️

IP Protection

—

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Epigene Channel LLC?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.